Skip to content

Gamification-Augmented Home-Based Exercise for Peripheral Artery Disease

Gamification-Augmented Home-Based Exercise for Peripheral Artery Disease (GAMEPAD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04536012
Acronym
GAMEPAD
Enrollment
103
Registered
2020-09-02
Start date
2020-10-05
Completion date
2024-01-08
Last updated
2025-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Artery Disease

Brief summary

A randomized trial of a gamification-enhanced home-based walking program compared with a standard home-based walking program in patients with intermittent claudication. Patients will be provided with a Fitbit device and set an exercise goal. Over the next 16 weeks, patients will receive text message reminders to exercise and daily steps will be tracked. Half of patients will be randomized to a gamified interface that leverages behavioral economic principles to encourage exercise.

Detailed description

Peripheral artery disease, atherosclerotic vascular disease involving the lower extremities, leads to functional limitation by causing leg pain with ambulation (intermittent claudication). Supervised exercise programs improve walking endurance in patients with intermittent claudication, but many patients are unable to travel to centers for treatment. In a recent trial, a home-based exercise program using wearable fitness trackers and telephone coaching failed to increase walking distance in patients with intermittent claudication, but this intervention did not leverage gamification or health behavior theory. Therefore, a randomized controlled trial was proposed comparing a gamification-enhanced home-based walking program with an attention control in patients with intermittent claudication. Patients in both arms will be provided with a wearable fitness tracker, wear the tracker for 2 weeks to establish a baseline daily step count and set a goal for step increase by the end of the 16-week study period. Patients in the attention control arm will receive daily text messages with a report of their previous day's step count. Patients in the gamification intervention arm will receive automated coaching via daily text messages and the intervention will also involve a precommittment pledge, slow ramp-up of step goals, weekly progression (or regression) through levels with loss-framing of points, and support from a family member or friend. After 16 weeks, change in daily step counts from baseline will be compared between study arms. Secondary behavioral phenotyping analyses will be undertaken to identify psychometric features associated with response to the gamification intervention.

Interventions

BEHAVIORALGamification and Social Incentives

Participants in the intervention arm will receive gamification and social incentives as part of the intervention. See arm descriptions for more detail.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years of age * Peripheral artery disease, defined as ankle-brachial index \< 0.90, lower extremity CT scan or ultrasound consistent with PAD, angiography with ≥ 70% stenosis in any lower extremity artery, or a history of medical or surgical revascularization * Owns a smartphone or tablet operating the iOS or Android operating system

Exclusion criteria

* Unable or unwilling to provide informed consent, including but not limited to cognitive or language barriers (reading or comprehension) * Critical limb ischemia, defined as rest pain, ulceration, or tissue loss involving the lower extremity * Planned lower extremity revascularization * Prior above or below the knee amputation * Require a wheelchair or the use of a walking aid other than a cane * Currently participating in a supervised exercise program for patients with PAD * Anticipated life expectancy less than 6 months * Any other reason why it is not feasible to complete the entire 6-month study * Step count \> 7500/day during the baseline data collection period

Design outcomes

Primary

MeasureTime frameDescription
Change in Daily Step Count16 WeeksChange in daily step count from baseline to the intervention period (main adjusted model)

Secondary

MeasureTime frameDescription
Change in Daily Step Count24 WeeksChange in daily step count from baseline to the follow-up period (main adjusted model)

Other

MeasureTime frameDescription
Change in Walking Impairment Questionnaire Score24 WeeksChange in Walking Impairment Questionnaire score from baseline to the end of the intervention period, and from baseline to the end of the follow-up period. Participants are asked to rate the degree of difficulty of various physical activities, ranging from 0 (unable) to 4 (no difficulty). Scores are divided by the maximum number of points and presented on a scale of 0%-100% where 0% indicates they are unable to do the activity and 100% indicates they have no difficulty.
Change in PROMIS Mobility, Pain Interference, and Satisfaction With Social Roles and Activities Scores24 WeeksChange in PROMIS (Patient-Reported Outcomes Measurement Information System) mobility, pain interference, and satisfaction with social roles and activities scores from baseline to the end of the intervention period, and from baseline to the end of the follow-up period. In the mobility survey, participants are asked to rate the level of difficulty of various physical activities on a scale from 1 to 5, where 1 means they are unable to do the activity and 5 means they have no difficulty. In the pain interference survey, they are asked to rate the degree to which pain interfered with various activities on a scale from 1 to 5, where 1 indicates pain did not interfere and 5 indicates pain very much interfered. For the satisfaction with social roles, participants are asked to rate how satisfied they are with their ability to perform various activities on a scale of 1-5, where 1 indicates they are not satisfied and 5 indicates they are very satisfied.
Change in SF-36 Physical Functioning Scale24 WeeksChange in SF-36 (36-Item Short Form Survey) physical functioning scale from baseline to the end of the intervention period, and from baseline to the end of the follow-up period. Participants are asked to self-report their health using 8 variously scaled scores. The scales are re-coded to values from 0 to 100, with 0 indicating lowest functioning/well-being and 100 indicating the highest.

Countries

United States

Participant flow

Participants by arm

ArmCount
Control
Via the Way to Health platform, all patients will receive daily text messages that inform them of their previous day's step count for 24 weeks.
52
Intervention
Participants have a 4-week ramp-up towards their step goal and are asked to maintain the goal for the rest of the study. They receive daily texts informing them if they met their step goal and biweekly texts to encourage walking for exercise. Participants are entered into a game. Each week they receive 70 points. If the step goal was met they keep their points. If not, they lose 10 points. At the end of the week if they have at least 40 points they move up a level. If not, they drop a level. Participants start in the middle of 5 levels. Participants choose a support partner who gets a weekly email with the participant's progress. We hold a 3-way phone call with the participant and partner to discuss ways they can help the participant meet their goal. Every 8 weeks, we have a follow up call if the participant is stuck in a lower level and restart them back at the middle level. In the follow-up period, participants continue to get a daily text stating if they met their step goal. Gamification and Social Incentives: Participants in the intervention arm will receive gamification and social incentives as part of the intervention. See arm descriptions for more detail.
51
Total103

Baseline characteristics

CharacteristicControlTotalIntervention
Age, Continuous70 years
STANDARD_DEVIATION 9.1
69.7 years
STANDARD_DEVIATION 8.6
69.4 years
STANDARD_DEVIATION 8.2
Annual Household Income
> $100,000
16 Participants34 Participants18 Participants
Annual Household Income
< $50,000
17 Participants35 Participants18 Participants
Annual Household Income
$50,000 to $100,000
19 Participants34 Participants15 Participants
Baseline Daily Step Count4540 Steps
STANDARD_DEVIATION 2379
4367 Steps
STANDARD_DEVIATION 2039
4191 Steps
STANDARD_DEVIATION 1627
BMI29.4 kg/m^2
STANDARD_DEVIATION 7.2
30.1 kg/m^2
STANDARD_DEVIATION 6.4
30.8 kg/m^2
STANDARD_DEVIATION 5.4
COPD7 Participants19 Participants12 Participants
Current Smoking7 Participants11 Participants4 Participants
Diabetes17 Participants37 Participants20 Participants
Education
College Graduate
32 Participants54 Participants22 Participants
Education
High School Graduate
7 Participants14 Participants7 Participants
Education
Some College
11 Participants33 Participants22 Participants
Education
Some High School
2 Participants2 Participants0 Participants
Education
College graduate
32 Participants54 Participants22 Participants
Education
High school graduate
7 Participants14 Participants7 Participants
Education
Some college
11 Participants33 Participants22 Participants
Education
Some high school
2 Participants2 Participants0 Participants
Goal Step Increase1160 Steps
STANDARD_DEVIATION 2033
1353 Steps
STANDARD_DEVIATION 1541
1549 Steps
STANDARD_DEVIATION 740
Heart Failure7 Participants12 Participants5 Participants
Hyperlipidemia37 Participants73 Participants36 Participants
Hypertension37 Participants83 Participants46 Participants
Kidney Disease10 Participants20 Participants10 Participants
Marital Status
Married
27 Participants57 Participants30 Participants
Marital Status
Other
17 Participants27 Participants10 Participants
Marital Status
Single
8 Participants19 Participants11 Participants
Prior MI16 Participants26 Participants10 Participants
Prior Use of Smartphone or Wearable to Track Steps35 Participants62 Participants27 Participants
Race/Ethnicity, Customized
Asian
2 Participants2 Participants0 Participants
Race/Ethnicity, Customized
Black
6 Participants16 Participants10 Participants
Race/Ethnicity, Customized
Hispanic
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Other
2 Participants3 Participants1 Participants
Race/Ethnicity, Customized
White
42 Participants81 Participants39 Participants
Region of Enrollment
United States
52 Participants103 Participants51 Participants
San Diego Claudication Questionnaire
Atypical Leg Pain
26 Participants53 Participants27 Participants
San Diego Claudication Questionnaire
Classic Claudication
9 Participants21 Participants12 Participants
San Diego Claudication Questionnaire
No Symptoms
17 Participants29 Participants12 Participants
Sex: Female, Male
Female
27 Participants49 Participants22 Participants
Sex: Female, Male
Male
25 Participants54 Participants29 Participants
Stroke8 Participants12 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 521 / 51
other
Total, other adverse events
13 / 5221 / 51
serious
Total, serious adverse events
3 / 526 / 51

Outcome results

Primary

Change in Daily Step Count

Change in daily step count from baseline to the intervention period (main adjusted model)

Time frame: 16 Weeks

ArmMeasureValue (MEAN)Dispersion
ControlChange in Daily Step Count783 steps per dayStandard Deviation 2441
InterventionChange in Daily Step Count1770 steps per dayStandard Deviation 2481
Secondary

Change in Daily Step Count

Change in daily step count from baseline to the follow-up period (main adjusted model)

Time frame: 24 Weeks

ArmMeasureValue (MEAN)Dispersion
ControlChange in Daily Step Count717 steps per dayStandard Deviation 2410
InterventionChange in Daily Step Count1786 steps per dayStandard Deviation 2476
Other Pre-specified

Change in PROMIS Mobility, Pain Interference, and Satisfaction With Social Roles and Activities Scores

Change in PROMIS (Patient-Reported Outcomes Measurement Information System) mobility, pain interference, and satisfaction with social roles and activities scores from baseline to the end of the intervention period, and from baseline to the end of the follow-up period. In the mobility survey, participants are asked to rate the level of difficulty of various physical activities on a scale from 1 to 5, where 1 means they are unable to do the activity and 5 means they have no difficulty. In the pain interference survey, they are asked to rate the degree to which pain interfered with various activities on a scale from 1 to 5, where 1 indicates pain did not interfere and 5 indicates pain very much interfered. For the satisfaction with social roles, participants are asked to rate how satisfied they are with their ability to perform various activities on a scale of 1-5, where 1 indicates they are not satisfied and 5 indicates they are very satisfied.

Time frame: 24 Weeks

ArmMeasureGroupValue (MEAN)
ControlChange in PROMIS Mobility, Pain Interference, and Satisfaction With Social Roles and Activities ScoresPROMIS Pain-2.2 units on a scale
ControlChange in PROMIS Mobility, Pain Interference, and Satisfaction With Social Roles and Activities ScoresPROMIS Social Function-0.6 units on a scale
InterventionChange in PROMIS Mobility, Pain Interference, and Satisfaction With Social Roles and Activities ScoresPROMIS Pain-4.7 units on a scale
InterventionChange in PROMIS Mobility, Pain Interference, and Satisfaction With Social Roles and Activities ScoresPROMIS Social Function0.3 units on a scale
Other Pre-specified

Change in SF-36 Physical Functioning Scale

Change in SF-36 (36-Item Short Form Survey) physical functioning scale from baseline to the end of the intervention period, and from baseline to the end of the follow-up period. Participants are asked to self-report their health using 8 variously scaled scores. The scales are re-coded to values from 0 to 100, with 0 indicating lowest functioning/well-being and 100 indicating the highest.

Time frame: 24 Weeks

ArmMeasureGroupValue (MEAN)
ControlChange in SF-36 Physical Functioning ScalePhysical functioning0.3 units on a scale
ControlChange in SF-36 Physical Functioning ScaleEmotional well-being0.9 units on a scale
ControlChange in SF-36 Physical Functioning ScaleRole functioning/emotional5.7 units on a scale
ControlChange in SF-36 Physical Functioning ScaleSocial functioning7.4 units on a scale
ControlChange in SF-36 Physical Functioning ScaleRole functioning/physical5.9 units on a scale
ControlChange in SF-36 Physical Functioning ScalePain3.5 units on a scale
ControlChange in SF-36 Physical Functioning ScaleEnergy/fatigue3 units on a scale
ControlChange in SF-36 Physical Functioning ScaleGeneral Health1.2 units on a scale
ControlChange in SF-36 Physical Functioning ScaleHealth Change5.3 units on a scale
InterventionChange in SF-36 Physical Functioning ScaleGeneral Health4.2 units on a scale
InterventionChange in SF-36 Physical Functioning ScaleHealth Change16.9 units on a scale
InterventionChange in SF-36 Physical Functioning ScalePhysical functioning6.7 units on a scale
InterventionChange in SF-36 Physical Functioning ScaleRole functioning/physical12.8 units on a scale
InterventionChange in SF-36 Physical Functioning ScaleRole functioning/emotional3.9 units on a scale
InterventionChange in SF-36 Physical Functioning ScaleEnergy/fatigue3 units on a scale
InterventionChange in SF-36 Physical Functioning ScaleEmotional well-being2.4 units on a scale
InterventionChange in SF-36 Physical Functioning ScaleSocial functioning2 units on a scale
InterventionChange in SF-36 Physical Functioning ScalePain10.5 units on a scale
Other Pre-specified

Change in Walking Impairment Questionnaire Score

Change in Walking Impairment Questionnaire score from baseline to the end of the intervention period, and from baseline to the end of the follow-up period. Participants are asked to rate the degree of difficulty of various physical activities, ranging from 0 (unable) to 4 (no difficulty). Scores are divided by the maximum number of points and presented on a scale of 0%-100% where 0% indicates they are unable to do the activity and 100% indicates they have no difficulty.

Time frame: 24 Weeks

ArmMeasureGroupValue (MEAN)
ControlChange in Walking Impairment Questionnaire ScoreWIQ Stair Climbing6.4 units on a scale
ControlChange in Walking Impairment Questionnaire ScoreWIQ Overall1.4 units on a scale
ControlChange in Walking Impairment Questionnaire ScoreWIQ Distance-3.8 units on a scale
ControlChange in Walking Impairment Questionnaire ScoreWIQ Speed1.7 units on a scale
InterventionChange in Walking Impairment Questionnaire ScoreWIQ Overall5.7 units on a scale
InterventionChange in Walking Impairment Questionnaire ScoreWIQ Speed4.8 units on a scale
InterventionChange in Walking Impairment Questionnaire ScoreWIQ Stair Climbing9.5 units on a scale
InterventionChange in Walking Impairment Questionnaire ScoreWIQ Distance7.3 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026